← SynDRA
OMAVELOXOLONE
SynDRA canonical compound SYN0039856 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NFE2L2 |
|---|
| Mechanism of action | nitric oxide production inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- NFE2L2 ACTIVATOR
- Nuclear factor erythroid 2-related factor 2 activator
- nitric oxide production inhibitor
Drug classes
- Cytochrome P450 3A4 Inducers
- Cytochrome P450 2C8 Inducers
ATC classes
- N07X · OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- skyclarys
- RTA-408
- Omaveloxolona
- Skyclarys
- RJCWBNBKOKFWNY-HGNIWHNWSA-N
- N-((4aR,6aR,6bS,12aS,14aR,14bR)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicen-4a-yl)-2,2-difluoropropanamide
- AKOS030526563
- G69Z98951Q
- RTA 408
- SKYCLARYS
- omaveloxolona
- omaveloxolonum
- RefChem:58294
- DTXCID301569878
- Nrf1-activator-1
- Omaveloxolone [INN]
- RTA408
- MFCD28167769
- UNII-G69Z98951Q
- Skyclarys (TN)
- Omaveloxolone (USAN/INN)
- RTA-408(Omaveloxolone)?
- OMAVELOXOLONE [USAN]
- OMAVELOXOLONE [WHO-DD]
- GTPL7573
- orb1300346
- SCHEMBL15349371
- EX-A541
- C33H44F2N2O3
- CHEBI:229661
- RJCWBNBKOKFWNY-IDPLTSGASA-N
- GLXC-90493
- AKOS037648676
- NCGC00390577-04
- AC-37100
- BS-15146
- HY-12212
- SY284909
Look up OMAVELOXOLONE in the interactive SynDRA portal →